Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04194554 |
| Title | A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS) |
| Acronym | ASCLEPIuS |
| Recruitment | Active, not recruiting |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University of Michigan Rogel Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Michigan Rogel Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
| Mayo Clinic | Rochester | Minnesota | 55901 | United States | Details | |
| Cornell University | New York | New York | 10065 | United States | Details | |
| Weill Cornell Medicine | New York | New York | 10065 | United States | Details | |
| University Hospitals Seidman Cancer Center | Cleveland | Ohio | 44106 | United States | Details | |
| University of Texas Southwestern | Dallas | Texas | 75390 | United States | Details |